GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AxoGen AXGN · USD

Health Care · US listing · 🇺🇸 United States

Compare

50.64

+1.24%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$225.2m

FY2016FY2025

Net income

−$15.7m

FY2016FY2025

Free cash flow

−$2.9m

FY2016FY2025

Shareholders' equity

$128.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$225.2m$187.3m$159.0m$138.6m$127.4m$112.3m$106.7m$83.9m$60.4m$41.1m
Gross profit$167.4m$142.0m$121.9m$108.8m$104.4m$90.7m$89.4m$71.0m$51.1m$34.6m
Research and development$32.9m$27.8m$27.3m$25.6m$24.2m$17.8m$17.5m$11.8m$6.7m$4.2m
Operating income−$7.8m−$1.8m−$20.8m−$29.7m−$25.6m−$22.7m−$31.4m−$21.2m−$8.0m−$8.1m
Net income−$15.7m−$10.0m−$21.7m−$28.9m−$27.0m−$23.8m−$29.1m−$22.4m−$10.4m−$14.4m
Diluted earnings per share-0.33-0.21-0.50-0.68-0.65-0.59-0.74-0.58-0.31-0.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$221.7m$203.7m$196.8m$195.4m$208.0m$201.4m$154.6m$160.2m$58.9m$46.4m
Cash and short-term investments$35.5m$33.5m$31.0m$48.8m$84.1m$104.0m$96.5m$116.6m$36.5m$30.0m
Total liabilities$92.8m$99.8m$101.2m$94.4m$95.5m$78.2m$22.5m$13.2m$33.7m$31.4m
Debt$48.4m$47.5m$46.6m$45.7m$44.8m$32.1m—$100,000$24.5m$24.3m
Shareholders' equity$128.8m$103.9m$95.7m$101.0m$112.5m$123.1m$132.2m$147.0m$25.2m$14.9m
Shares outstanding47m48m43m42m41m40m39m39m34m33m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$812,000$4.5m−$5.7m−$16.1m−$13.4m−$9.6m−$19.9m−$17.9m−$9.2m−$11.2m
Capital spending−$3.7m−$4.5m−$14.9m−$21.3m−$28.4m−$22.6m−$5.2m−$6.6m−$1.3m−$1.2m
Free cash flow−$2.9m$11,000−$20.6m−$37.3m−$41.8m−$32.2m−$25.1m−$24.5m−$10.5m−$12.4m
Dividends paid—————−$670,000————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$69.7m$61.5m$59.9m$60.1m$56.7m$48.6m$49.4m$48.6m
Gross profit$50.7m$46.2m$44.4m$46.0m$42.0m$34.9m$37.6m$36.4m
Operating income−$2.2m−$2.8m−$9.8m$2.5m$2.6m−$1.6m$2.3m−$316,000
Net income−$1.5m−$19.6m−$13.2m$708,000$579,000−$3.8m$450,000−$1.9m
Diluted earnings per share-0.03-0.37-0.280.020.01-0.080.01-0.04
Cash from operations$1.0m$1.0m$3.0m$3.0m$7.0m−$13.0m$8.0m$3.0m
Capital spending—−$2.0m−$1.0m−$1.0m———−$1.0m
Free cash flow—−$1.0m$2.0m$2.0m———$2.0m
Total assets$304.9m$289.5m$221.7m$216.4m$205.5m$196.2m$203.7m$192.0m
Cash and short-term investments$94.6m$82.7m$35.5m$35.8m$35.9m$22.1m$33.5m$24.5m
Debt$2.0m$2.1m$50.8m$50.5m$50.1m$49.8m$49.5m$49.1m
Shareholders' equity$256.3m$244.8m$128.8m$120.8m$112.3m$105.4m$103.9m$99.4m

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin74.3%75.8%76.6%78.5%82.0%80.8%
Operating margin-3.6%-0.9%-11.9%-20.4%-20.1%-20.2%
Net margin-7.0%-5.3%-13.7%-20.9%-21.2%-21.2%
Return on equity-12.2%-9.6%-22.7%-28.7%-24.0%-19.3%
Return on assets-7.1%-4.9%-11.0%-14.8%-13.0%-11.8%
Free cash flow yield0.2%0.4%0.4%0.2%0.7%0.7%
Revenue growth20.2%17.8%14.7%8.8%13.4%5.2%
Earnings growth57.6%-54.1%-25.0%7.3%13.4%-18.3%
Current ratio5.11x3.24x2.89x4.13x5.23x6.36x
Debt to equity0.39x0.48x0.50x0.67x0.60x0.44x
Equity ratio58.1%51.0%48.6%51.7%54.1%61.2%
Interest coverage-1.04x-0.21x-6.66x-45.39x-18.90x-21.57x
R&D as a share of sales14.6%14.8%17.2%18.5%19.0%15.9%
Buybacks as a share of market value2.4%-11.7%-1.8%-2.0%-3.0%-1.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.6%14.9%23.5%
Operating income-35.8%-19.2%-1.6%
Net income-18.4%-8.0%1.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin75.0%76.0%77.4%79.1%
Operating margin-2.3%-8.5%-11.4%-14.7%
Net margin-6.2%-10.7%-13.4%-17.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-97.8-79.5-13.5-14.6-14.4-30.3-24.3-35.3-91.7-20.3
Price to sales6.84.21.93.03.06.46.69.415.87.1

Market value over time

30 Nov 2016 to 30 Oct 2026, in USD

$251.8m$3.04bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return121%103%-30%10%-46%-1%-4%-36%224%71%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Jan 2010.

FY2009FY2005
Paid in the year1.000.06
  • 21-for-20 split · 11 Jul 1994
  • 21-for-20 split · 12 Jul 1993
  • 21-for-20 split · 10 Jul 1992

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.